Bromfenac 0.09%Manufacturer Supplier in PCD Pharma Franchise
BRAND NAME FOR Bromfenac 0.09% IN PCD PHARMA FRANCHISE – Bromfenac 0.09%
COMPOSITION: Bromfenac 0.09%
For rates and Schemes – Contact 8284010553
Introduction of Bromfenac 0.09%
Bromfenac 0.09% is primarily prescribed for the reduction of inflammation and pain associated with cataract surgery. This medication works by inhibiting the enzymes that cause inflammation, thereby providing relief to patients during the critical postoperative period. Bromfenac 0.09% is typically administered as an ophthalmic solution, ensuring targeted delivery and rapid onset of action. By effectively managing inflammation and pain, Bromfenac 0.09% plays a crucial role in enhancing patient comfort and accelerating the healing process.
Uses of Bromfenac 0.09%
Moxifloxacin 0.5% + Bromfenac 0.09% is a dual-action ophthalmic solution that combines the benefits of two potent agents. Moxifloxacin, a broad-spectrum antibiotic, is effective against a range of bacterial pathogens. Bromfenac, a non-steroidal anti-inflammatory drug (NSAID), provides relief from inflammation and pain. This combination is typically used to treat:
- Bacterial Conjunctivitis: Moxifloxacin tackles the bacterial infection causing conjunctivitis, reducing redness, swelling, and discharge.
- Postoperative Inflammation: Following eye surgeries, such as cataract removal, Moxifloxacin 0.5% + Bromfenac 0.09% helps in managing both infection risks and inflammation, aiding in quicker recovery.
Side Effects of Bromfenac 0.09%
While Bromfenac 0.09% is generally well-tolerated, it is essential to be aware of potential side effects to ensure patient safety. Common side effects include:
- Eye irritation: Patients may experience mild discomfort or a burning sensation in the eyes.
- Blurred vision: Temporary blurring of vision may occur immediately after application.
- Headache: Some patients may report headaches as a side effect.
- Sensitivity to light: Increased sensitivity to light is a possible side effect.
- Redness of the eye: Mild redness in the treated eye may occur.
It is important for patients to consult their healthcare provider if they experience any severe or persistent side effects. Matins Pharma prioritizes patient safety and encourages open communication between patients and healthcare professionals to address any concerns promptly.
Safety Advice of Bromfenac 0.09%
To ensure the safe and effective use of Bromfenac 0.09%, patients should adhere to the following safety advice:
- Proper administration: Patients should follow the prescribed dosage and administration instructions provided by their healthcare provider. It is crucial to avoid contamination by not touching the dropper tip to any surface, including the eye.
- Contact lenses: Patients should remove contact lenses before applying Bromfenac 0.09% and wait at least 15 minutes before reinserting them.
- Avoiding infections: To prevent eye infections, patients should practice good hygiene, including washing hands thoroughly before applying the medication.
- Regular monitoring: Regular follow-up appointments with the healthcare provider are essential to monitor the healing process and ensure the medication’s effectiveness.
- Informing the healthcare provider: Patients should inform their healthcare provider of any other medications they are taking to avoid potential drug interactions.
Dosage of Bromfenac 0.09%
The recommended dosage of Bromfenac 0.09% is one drop in the affected eye(s) once or twice daily, as directed by the healthcare provider. The treatment usually begins one day before cataract surgery and continues for up to 14 days post-surgery. It is important to adhere to the prescribed dosage and not exceed the recommended duration of use to avoid potential complications. Matins Pharma ensures that every batch of Bromfenac 0.09% is manufactured with precision, adhering to stringent quality control measures to provide patients with a safe and effective product.
Bromfenac 0.09% begins to work relatively quickly, providing relief from inflammation and pain within a few hours of administration. Patients typically notice a significant reduction in discomfort and swelling within the first few days of use. The full therapeutic effect is usually achieved within one to two weeks of consistent application. Matins Pharma’s dedication to quality ensures that Bromfenac 0.09% delivers reliable and prompt results, contributing to a smoother and more comfortable recovery process for patients undergoing cataract surgery.
MATINS PHARMA IS A LEADING MANUFACTURER / SUPPLIER OF Bromfenac 0.09%
In conclusion, Matins Pharma, a leading manufacturer and supplier in the pharmaceutical industry, offers high-quality Bromfenac 0.09% under the brand name Bromfenac 0.09%
Matins Pharma is one of the fastest growing Manufacturers suppliers pan India.
WE AT MATINS PHARMA AIM FOR :
- 100% quality assurance with high efficacy and excellent results
- Improved delivery experience and shorter delivery times
- Best in class service levels through regular communication with our Supplier partners and sharing the same in a transparent manner
- Customer satisfaction and understanding the latent needs of the our business partners
- Enriching our product mix by each passing day so as to provide you everything under one roof
Why Matins Pharma is among the best PCD Pharma Franchise Company in India:
- 100 % Quality Assurance
- Direct Dealing with Company Owners
- Very High Efficacy, WHO/GMP/GLP Certified Products
- Wide Product Range
- Best in Class Packings with UV Drip Off Finish
- High Margin Products with genuine rates
- Same Day Dispatch with trusted delivery partners
- Fair and Transparent Dealing – 100 % Commitment to agreement
Address: D-1A, Ahluwalia Complex Vill. Fatehpur, Sector 20, Panchkula, 134117, Haryana
Contact Number: 82840 10553, 99155 69932, 94175 06219India
We at Matins Pharma provide wide range of quality products. We offer the following ranges in PCD Pharma Franchise:
